45.2 F
New York
Monday, December 4, 2023

Aldeyra reports mid-stage results for retinitis pigmentosa candidate

Must read

Share Me

[ad_1]

Excellent progress! There is currently no effective treatment for RP, which causes tunnel vision, then blindness. This study, along with recent results for Chronic Cough, Dry Eye, and Allergic Conjunctivitis, further validates ALDX’s RASP platform.

[ad_2]

Source link

- Advertisement -spot_img

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article